-
PDF
- Split View
-
Views
-
Cite
Cite
Ann Mary Alex, Tom Ruvio, Kai Xia, Shaili C Jha, Jessica B Girault, Li Wang, Gang Li, Dinggang Shen, Emil Cornea, Martin A Styner, John H Gilmore, Rebecca C Knickmeyer, Influence of gonadal steroids on cortical surface area in infancy, Cerebral Cortex, Volume 32, Issue 15, 1 August 2022, Pages 3206–3223, https://doi.org/10.1093/cercor/bhab410
- Share Icon Share
Abstract
Sex differences in the human brain emerge as early as mid-gestation and have been linked to sex hormones, particularly testosterone. Here, we analyzed the influence of markers of early sex hormone exposure (polygenic risk score (PRS) for testosterone, salivary testosterone, number of CAG repeats, digit ratios, and PRS for estradiol) on the growth pattern of cortical surface area in a longitudinal cohort of 722 infants. We found PRS for testosterone and right-hand digit ratio to be significantly associated with surface area, but only in females. PRS for testosterone at the most stringent P value threshold was positively associated with surface area development over time. Higher right-hand digit ratio, which is indicative of low prenatal testosterone levels, was negatively related to surface area in females. The current work suggests that variation in testosterone levels during both the prenatal and postnatal period may contribute to cortical surface area development in female infants.
Introduction
Although men and women are similar in many ways, certain health risks and behaviors are more common in one sex as compared with the other. For example, certain psychiatric illnesses including eating disorders and depression are more common in women, while certain neurodevelopmental disorders including autism and ADHD are more common in males (Green et al. 2018). The reasons for these differences are undoubtedly complex and multifactorial. However, they may reflect, in part, sex differences in human brain structure. The adult human brain is 9–12% larger in males when compared with females (Ruigrok et al. 2014; Ritchie et al. 2018; Kaczkurkin et al. 2019). Differences in overall brain size are accompanied by substantial sex differences in cortical surface area with males having greater surface area than females. Cortical thickness, however, is higher for females (Ritchie et al. 2018). Regional sex differences in cortical volume, surface area, and thickness, and the volumes of subcortical brain structures such as the hippocampus, nucleus accumbens, amygdala, caudate nucleus, putamen, and thalamus are primarily a reflection of these global differences, although there are some regions that demonstrate sex differences even when adjusting for global measures (Ritchie et al. 2018; Wierenga, Sexton, et al. 2018b). How these differences emerge across human development, as well as the mechanisms responsible for these differences, remains an active area of investigation and is the primary focus of the current manuscript.
Some sex differences emerge during adolescence and may be linked to the surge in sex hormone production that accompanies activation of the hypothalamic–pituitary–gonadal (HPG) axis in puberty (Vigil et al. 2016). Many different research teams have reported associations between circulating sex steroids and brain morphometry, or brain morphometry change during adolescence (Neufang et al. 2009; Peper et al. 2009; Bramen et al. 2011, 2012; Nguyen et al. 2013; Herting et al. 2014, 2015; Koolschijn et al. 2014; Wierenga, Bos, et al. 2018a), though the pattern of results differs somewhat between studies in terms of the specific regions affected and in the direction of effect. Other sex differences emerge much earlier in life. For example, sex differences in cortical volume can be observed in midgestation (Studholme et al. 2020) and 2 weeks postnatal (Dean et al. 2018; Jha et al. 2019). Male brains are about 6% larger than female brains at birth and continue to grow faster postnatally (Holland et al. 2014; Wierenga et al. 2014; Gilmore et al. 2018). As in adults, greater brain size in males appears to be more closely related to cortical surface area than cortical thickness. Approximately 4% of variation in surface area at 1 month of age can be accounted by sex (Jha et al. 2019). In contrast, sex is not a significant predictor of cortical thickness in early infancy (Jha et al. 2019), and male and female children exhibit similar trajectories of cortical thickness development when examining individual lobes or the entire brain (Raznahan et al. 2011; Koolschijn and Crone 2013).
Sex differences in the early development of cortical surface area may be the result of gonadal steroids acting in the prenatal or early postnatal period. In human males, placental choriogonadotropin induces testicular mesenchymal cells to differentiate into Leydig cells and stimulates testosterone production beginning in the ninth gestational week. The male HPG axis is active by midgestation, producing a peak in gonadotropin levels and a surge in testosterone production, with the highest levels reached between 11 and 17 weeks (Reyes et al. 1974; Shigeo et al. 1977; Tapanainen et al. 1981). Human female fetuses also experience this surge in gonadotropin production and produce higher levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) than human male fetuses (Clements et al. 1976; Kaplan and Grumbach 1976; Debieve et al. 2000). However, estrogen exposure is similar between the sexes, since the ovaries produce relatively little in comparison to the placenta (Lanciotti et al. 2018). Increases in placental estrogen eventually suppress the activity of the fetal HPG axis in both males and females. Immediately postbirth, males experience a brief surge in LH, followed by a transient rise in testosterone, which lasts about 12 h. About 1 week later, male testosterone levels begin to increase again, peaking at 1–3 months (Forest et al. 1973; Andersson et al. 1998; Kuiri-Hänninen et al. 2011). In females, estradiol increases postbirth and remains high until at least the sixth month of life (Schmidt et al. 2002; Chellakooty et al. 2003; Kuiri-Hänninen et al. 2013). This transient activation of the HPG axis in the first 6 months of infancy is referred to as the minipuberty in both males and females (Lanciotti et al. 2018; Vasung et al. 2019; Becker and Hesse 2020), and its potential effect on brain development is poorly understood.
A rich body of preclinical research, primarily conducted in rodents, shows that prenatal and neonatal sex steroids influence numerous neurodevelopmental processes and are ideal candidates for exerting epigenetic effects on the developing brain (McCarthy and Crews 2008). However, complementary studies in human infants are lacking. This is, in large part, due to the challenges of measuring hormonal exposure in the prenatal and early postnatal period, as well as the challenges of imaging infants and young children. There are several small studies that attempted to link measurements of the prenatal hormonal milieu to neuroimaging phenotypes assessed in late childhood or adulthood. Kallai et al. (2005) reported that the 2D:4D digit ratio, a putative indicator of the intrauterine ratio of testosterone to estrogen, was associated with the volume of certain hippocampal subregions in 40 adult women but was not associated with volumes of the amygdala or cerebral cortex (Kallai et al. 2005). Darnai et al. (2016) reported significant positive correlations between digit ratio and total cerebral cortex, total cerebellar white matter, and total cerebellar cortex in 32 adult males but did not observe significant correlations in females for any of the variables they examined, which included total intracranial volume, total cerebral white matter, total cerebral cortex, total cerebellar white matter, total cerebellar cortex, and total ventricular volume (Darnai et al. 2016). Lombardo et al. (2012) reported that amniotic testosterone levels predict increased local gray matter (GM) volume in the right temporoparietal junction/posterior superior temporal sulcus (RTPJ/pSTS) and bilateral somatosensory, motor, and premotor cortex, and decreased local GM volume along both sides of the Sylvian fissure in 28 boys between 8 and 11 years of age (Lombardo et al. 2012). Our own group has tested whether 2D:4D digit ratio or efficiency of the androgen receptor, indexed by the number of CAG repeats in androgen receptor (AR) gene, predicts global and local brain volumes around 2 weeks of age and found minimal, sex-specific effects on local gray matter volume (Knickmeyer, Wang, Zhu, Geng, Woolson, Hamer, Konneker, Styner, et al. 2014b). We have also reported that genetic variation in the estrogen receptor is associated with neonatal brain volume (Knickmeyer, Wang, Zhu, Geng, Woolson, Hamer, Konneker, Lin, et al. 2014a).
The current study significantly expands upon our earlier work by evaluating five different markers of early hormonal exposure in relation to cortical surface area (SA) in a large, longitudinal cohort of infants. These markers include 1) a polygenic risk score (PRS) for serum testosterone, 2) salivary testosterone levels measured at 3 months of age, 3) number of CAG repeats in the androgen receptor (AR) gene, 4) a PRS for serum estradiol, and 5) 2D:4D digit ratios. We focused on cortical surface area because it shows robust sex differences in this cohort and, similar to adults, appears to be the primary driver of sex differences in overall brain volumes in infancy (Jha et al. 2019). We hypothesized that these markers would be associated with cortical surface area measured at 1 month postbirth, 1 year, and 2 years of age.
Materials and Methods
Participants
A total of 722 infants are included in this study (367 singletons and 355 twins). All infants were participants in the UNC Early Brain Development Study (EBDS), a prospective, longitudinal cohort study that has collected neuroimaging data around 1, 12, and 24 months of age (Knickmeyer et al. 2008, 2017; Gilmore et al. 2010). Some EBDS participants also provided buccal swabs for the analysis of DNA, saliva samples for hormone analysis, and/or black and white photocopies of the left- and right hand for the calculation of the 2D:4D digit ratio, an anthropometric proxy for prenatal gonadal steroid exposure. Infants with these ancillary samples and high-quality measurements of cortical surface area from at least one study visit are the focus of the current report. Mothers were recruited during the second trimester of pregnancy from the outpatient obstetrics and gynecology clinics at UNC hospitals. Exclusion criteria at enrollment were the presence of abnormalities on fetal ultrasound or major medical or psychotic illness in the mother. Written consent of each subject’s mother or father was obtained prior to experimental procedures. The study was conducted with the approval of the Institutional Review Board of the University of North Carolina (UNC) School of Medicine and the Institutional Review Board of Michigan State University and complies with national legislation and the Code of Ethical Principles for Medical Research Involving Human Subjects of the World Medical Association (Declaration of Helsinki).
MRI Data Acquisition and Processing
Images were acquired on a Siemens Allegra head-only 3T scanner [N = 456 (1 month); N = 331 (12 months); N = 245 (24 months)] or a Siemens TIM Trio 3T scanner [N = 84 (1 month); N = 69 (12 months); N = 62 (24 months)] (Siemens Medical Systems, Erlangen, Germany). Children were scanned unsedated while asleep, fitted with ear protection, and with their heads secured in a vacuum-fixation device. T1-weighted images, which are used for cortical reconstruction at 12 and 24 months of age, were obtained with 3D magnetization prepared rapid gradient echo sequences (MP-RAGE). T1 acquisition parameters for the Allegra were TR = 1820 ms, inversion time = 1100 ms, echo time = 4.38 ms, flip angle = 7°, resolution = 1 × 1 × 1 mm (N = 576). T1 acquisition parameters for the Trio were TR = 1860–1900 ms, TE = 3.74 ms, flip angle = 7°, spatial resolution = 1 mm × 1 mm × 1 mm (N = 131). Proton density and T2-weighted images, which are used for cortical reconstruction at 1 month, were obtained on the Allegra with turbo-spin echo sequences. Our standard TSE parameters were TR = 6200 ms, TE1 = 20 ms, TE2 = 119 ms, flip angle = 150°, resolution = 1.25 × 1.25 × 1.95 mm (N = 225). A “fast” turbo-spin echo sequence was collected on the Allegra for neonates who had trouble sleeping through the scan session, using a decreased TR, a smaller image matrix, and fewer slices (TR range = 5270–5690 ms, TE1 range = 20–21 ms, TE2 range = 119–124 ms, flip angle = 150°, spatial resolution = 1.25 mm × 1.25 mm × 1.95 mm, N = 226). For acquisition in TIM Trio, some children were scanned using a TSE protocol (TR = 6200 ms, TE1 = 17, TE2 = 116 ms, flip angle = 150°, spatial resolution = 1.25 mm × 1.25 mm × 1.95 mm, N = 8), while the rest were scanned using a 3-D T2 SPACE protocol (TR = 3200 ms, TE = 406, flip angle = 120°, spatial resolution = 1 mm × 1 mm × 1 mm, N = 79). All images in this study were visually checked and rated for motion artifacts using a 4-point visual scale based on (Blumenthal et al. 2002), where none = 1, mild = 2, moderate = 3, and severe = 4.
For deriving SA measures, a previously described pipeline was used (Li et al. 2016; Jha et al. 2019). Images were resampled into 1 × 1 × 1 mm3 resolution, skull-stripped, and then had the cerebellum and brain stem removed (Shi et al. 2012). A standalone infant-specific patch–driven coupled level sets method for segmentation of gray matter, white matter, and cerebrospinal fluid (CSF) during infancy was jointly applied (Wang et al. 2014). Inner and outer cortical surfaces were first constructed using the process described in Li et al. with the inner cortical surface defined by the interface between white matter and gray matter, and the outer cortical surface defined by the interface between gray matter and CSF (Li et al. 2012, 2014). SA was measured after the surface reconstruction. There were 615 infants with high-quality measurements of global SA at 1 month, 410 infants with high-quality measurements of global SA at 12 months, and 314 infants with high-quality measurements of global SA at 24 months.
Salivary Testosterone Measurement
Saliva was collected approximately 3 months postbirth (N = 291). Collection visits were scheduled for 9:00 in the morning. About 1 mL of passive drool was collected from each participant using a suction catheter (Centurion Healthcare Products, Howell, MO). All samples were frozen within 4 h and stored in an −80 °C freezer. Enzyme immunoassay using a commercially available kit (Salimetrics, State College, PA) was used for the measurement of salivary testosterone. The intra-assay precision for samples with low testosterone levels (mean 18.12 pg/mL) is 6.7%; for high testosterone levels (mean 188.83 pg/mL), it is 2.5%. Interassay precision for samples with low testosterone levels (mean 19.6 pg/mL) is 14.05%; for high testosterone levels (mean 199.08 pg/mL), it is 5.6%. Percent recovery for this assay varies from 92% to 111.4%. The minimal concentration of testosterone that can be distinguished from 0 is <1.0 pg/mL. The saliva–serum correlation is stronger for males, r = 0.91, than for females, r = 0.61 (Nahoul et al. 1986). All samples were evaluated for blood contamination using the Salimetrics Salivary Blood Contamination Enzyme Immunoassay kit, which quantitatively measures transferrin. Transferrin is a large protein that is present in abundance in blood, but that is normally present in only trace amounts in saliva. Intra-assay precision for samples with high (3.88 mg/dL) transferrin levels is 10.2%, and for samples with low (0.42 mg/dL) transferrin levels, it is 4.9%. Interassay precision is 7.1% for low (1.02 mg/dL) and 7.2% for high (4.93 mg/dL) transferrin levels. Percent recovery varies from 91.9% to 101.5%. The minimal concentration of transferrin that can be distinguished from zero is 0.08 mg/dL. Mean transferrin levels in the samples were higher than expected, which suggests a possibility for blood contamination. Furthermore, the untransformed transferrin variable showed a high level of skewness. To overcome these issues, we excluded three individuals who were outliers for transferrin level (above 6.68) and included log(10) transferrin as a covariate in all analyses that included salivary testosterone.
Digit Ratio Measurements
Digit ratio measurements were taken at three visits at 1 month postbirth (N = 436), at 12 months of age (N = 354), and at 24 months (N = 352). Black and white photocopies of both the left- and right hand of participating children were collected. Measurements of 2nd and 4th digit length were taken from photocopies using Vernier calipers with an accuracy of ±0.02 mm and repeatability of 0.01 mm. The 2D:4D ratio was calculated from digit length measured from the basal crease of the digit proximal to the palm to the tip of the digit. Each digit was measured twice with a minimum of 1 day between measurements. Two raters performed the 2D:4D measurements. The raters were blind to subjects’ sex. While the raters were not given explicit information as regards subject age or ethnicity, the photocopies themselves provide some limited information relevant to these parameters (e.g., size and shape of hand and skin tone). Right versus left hand could be determined from the photocopies themselves. The measurement had high inter-rater reliability for both right- and left hand as evidenced from ICC at 1 month (0.89, 0.87), 12 months (0.91, 0.87), and 24 months (0.91, 0.9). ICC for comparison of right- and left-hand digit ratios across years showed moderate correlation at 1 month (0.39), 12 months (0.39), and 24 months (0.36). ICC across ages for the right-hand digit ratio was 0.41 and the left-hand digit ratio 0.37, which suggests a medium correlation over the time points.
Genotyping
CAG Repeats
CAG repeats were genotyped using buccal DNA samples. DNA was extracted using standard methods as described in the Puregene DNA Purification Kit (Gentra Systems) using supplies from Qiagen (N = 401). After extraction, samples were aliquoted into 2 (23ul) tubes and stored at −80 °C. Prior to freezing, DNA quantity and quality (indexed by the 260/280 nm ratio) were assessed by spectrophotometer (Beckman DU640, Beckman-Coulter, Brea, CA). CAG repeat polymorphism was genotyped using the protocol adapted from Allen et al. (1992). First, a PCR spanning the CAG repeat polymorphism was performed. The forward primer was 1, 5′-FAM-GCTGTGAAGGTTGCTGTTCCTCAT-3′; the reverse primer was 2, 5′-TCCAGAATCTGTTCCAGAGCGTGC-3′ The PCR was carried out on an MJ Research PTC-2000 Thermocycler. The PCR product was purified using a Promega Wizard SV 96 PCR clean-up system using the standard protocol. The sizes of the PCR fragments for each sample were measured using a 3730 DNA Analyzer (Applied Biosystems, Foster City, CA) using the 600LIZ size standard for comparison. Only PCR products with a FAM labeled end are detected by the analyzer. Data were viewed using GeneMapper software (Applied Biosystems) to determine peak fragment length for each sample. Genotypes were called by visual observation of the peak fragment length within GeneMapper software. Peak fragment lengths were then converted to CAG repeat numbers.
Genome-Wide Genotyping
Genome-wide genotyping was performed using Affymetrix Axiom Genome-Wide LAT and Exome arrays on DNA extracted from buccal cells. During the early phase of the study, DNA was extracted as described in the prior section (CAG Repeats). During the later phase of the study, DNA was extracted using phenol/chloroform, quantitated via picogreen, aliquoted into multiple Sarstedt 1.5 mL tubes, and stored at −80 °C. Samples were randomized across 96-well plates. A common control sample was included in each plate. Principal component analysis (PCA) was used for assessing population stratification (Price et al. 2006). Imputation was performed with MACH-Admix (Liu et al. 2013) using the 1000 Genomes Project (1000G) reference panel (phase1_release_v3.20101123) (Altshuler et al. 2010, 2012). Mean R2 for varying minor allele frequency (MAF) categories and R2 cutoffs was calculated for evaluating the quality of imputed SNPs (Wright et al. 2014). SNPs with average R2> 0.8 were retained for further analysis. Samples with low DishQC (<0.82 for LAT array and <0.79 for Exome array), low call rates (<95%), outliers for homozygosity, sex or zygosity from genotypes inconsistent with reported phenotypes, ancestry outliers, excessive relatedness, and unexpected relatedness were removed. Individual SNPs that deviated from Hardy–Weinberg equilibrium (PHWE < 1 × 10–8) had low call rate (<95%), high Mendelian error rate (>0.1, based on five parent–child trios), and high deviation of allele frequency compared with European American and African American subsets from the 1000 Genomes Project (1000G, either P < 1 × 10−5 and frequency difference > 0.07 or frequency difference > 0.15) and that did not match 1000G EUR/AFR founders were also removed (Xia et al. 2017).
Polygenic Risk Score
Polygenic risk scores for serum testosterone and estradiol were generated based on a genome-wide association analysis (GWAS) of UK Biobank samples of unrelated individuals of European ancestry (N = 361 194 with 194 174 females and 167 020 males in the age range 40–69 years), controlling for age, age2, and principal coordinates 1–20 (Walters et al. 2019). Higher risk scores are indicative of higher levels of serum testosterone and serum estradiol in an individual. Because the genetic component underlying individual variation in testosterone and estradiol levels differs between males and females with limited overlap of genome-wide significant signals and opposing effects at many loci (Ruth et al. 2020), we generated sex-specific PRS for individuals based on genetic determinants. Because the predictive power of PRS is reduced in individuals whose genetic ancestry differs substantially from the ancestry of individuals in the original GWAS (Martin et al. 2019), we restricted our analyses to individual of Caucasian ancestry (n = 430). PRSice version 2 software was used for generation of PRSs (Choi and O’Reilly 2019). The generation followed a series of processes. SNPs present in only the base UK Biobank GWAS or target cohort were removed. Info score filtering threshold was kept at 0.8. SNPs with minor allele frequency less than 0.01 were excluded. Ambiguous (A/T or C/G) SNPs were also removed. SNPs in linkage disequilibrium (r2> 0.1) were removed using a process called clumping, leaving a single SNP in each 250 kb LD window with the smallest P value from the GWAS. The remaining SNPs were used to calculate PRSs for 6 P value thresholds (5*10−8, 0.001, 0.01, 0.05, 0.5, 1). We used multiple thresholds because this approach addresses noise arising from null SNPs that may be incorporated, especially at large P value thresholds, while capturing true, subtle signals that increase power for association. PRS for testosterone and estradiol was calculated using additive model for all individuals of Caucasian ancestry with genotype data.
Statistical Analysis
Statistical analysis was performed using R version 3.6.3. In the demographics, for categorical variables, we calculated frequency distributions, and for continuous variables, means and standard deviations were calculated. Fisher’s exact test and the Kruskal–Wallis test were used for analyzing differences between males and females in baseline categorical and continuous variables, respectively. For the dependent and predictor variables, we used a linear mixed model for analyzing sex effects controlling for maternal ethnicity. For sex effects on testosterone, we also controlled for log transferrin values.
Analysis of Surface Area
Results
Demographics
Table 1 shows both demographic and obstetric history features of the sample. Males and females were highly similar for all these features, although there is a nominally significant difference for maternal ethnicity. Details for the subsample used for PRS analysis are provided in Supplementary Table 1.
. | Total . | Males . | Females . | . | |
---|---|---|---|---|---|
. | . | n (%/SD) . | n (%/SD) . | n (%/SD) . | P value* . |
Sample size | 722 | 386 (53%) | 336 (47%) | ||
Mean gestational age (days) | 260.77 (19.62) | 260.54 (19.5) | 261.04 (19.78) | 0.614 | |
Mean birthweight in grams | 2831.43 (710.96) | 2877.92 (716.47) | 2778.01 (701.86) | 0.074 | |
Maternal age | 29.83 (5.85) | 29.73 (5.76) | 29.95 (5.97) | 0.512 | |
Paternal age | 32.41 (6.75) | 32.17 (6.7) | 32.68 (6.81) | 0.369 | |
Singletons/twins | 367/355 | 196/190 | 171/165 | 0.694 | |
Total family income | Low | 277 (38%) | 148 (38%) | 129 (38%) | 0.375 |
Medium | 339 (47%) | 183 (47%) | 156 (46%) | ||
High | 63 (9%) | 28 (7%) | 35 (10%) | ||
Maternal education | Secondary | 227 (31%) | 119 (31%) | 108 (32%) | 0.748 |
Tertiary | 494 (68%) | 266 (69%) | 228 (68%) | ||
Paternal education | Primary | 1 | 1 | 0.271 | |
Secondary | 257 (36%) | 130 (34%) | 127 (38%) | ||
Tertiary | 439 (61%) | 240 (62%) | 199 (59%) | ||
Maternal ethnicity | Asian | 13 (2%) | 11 (3%) | 2 (1%) | 0.028 |
Black | 170 (24%) | 89 (23%) | 81 (24%) | ||
American Indian or Alaskan Native | 4 (1%) | 4 (1%) | 0 | ||
White | 535 (74%) | 282 (73%) | 253(75%) | ||
Paternal ethnicity | Asian | 20 (3%) | 12 (2%) | 8 (2%) | 0.108 |
Black | 187 (26%) | 101 (26%) | 86 (26%) | ||
American Indian or Alaskan Native | 5 (1%) | 5 (1%) | |||
White | 499 (69%) | 265 (69%) | 234 (70%) |
. | Total . | Males . | Females . | . | |
---|---|---|---|---|---|
. | . | n (%/SD) . | n (%/SD) . | n (%/SD) . | P value* . |
Sample size | 722 | 386 (53%) | 336 (47%) | ||
Mean gestational age (days) | 260.77 (19.62) | 260.54 (19.5) | 261.04 (19.78) | 0.614 | |
Mean birthweight in grams | 2831.43 (710.96) | 2877.92 (716.47) | 2778.01 (701.86) | 0.074 | |
Maternal age | 29.83 (5.85) | 29.73 (5.76) | 29.95 (5.97) | 0.512 | |
Paternal age | 32.41 (6.75) | 32.17 (6.7) | 32.68 (6.81) | 0.369 | |
Singletons/twins | 367/355 | 196/190 | 171/165 | 0.694 | |
Total family income | Low | 277 (38%) | 148 (38%) | 129 (38%) | 0.375 |
Medium | 339 (47%) | 183 (47%) | 156 (46%) | ||
High | 63 (9%) | 28 (7%) | 35 (10%) | ||
Maternal education | Secondary | 227 (31%) | 119 (31%) | 108 (32%) | 0.748 |
Tertiary | 494 (68%) | 266 (69%) | 228 (68%) | ||
Paternal education | Primary | 1 | 1 | 0.271 | |
Secondary | 257 (36%) | 130 (34%) | 127 (38%) | ||
Tertiary | 439 (61%) | 240 (62%) | 199 (59%) | ||
Maternal ethnicity | Asian | 13 (2%) | 11 (3%) | 2 (1%) | 0.028 |
Black | 170 (24%) | 89 (23%) | 81 (24%) | ||
American Indian or Alaskan Native | 4 (1%) | 4 (1%) | 0 | ||
White | 535 (74%) | 282 (73%) | 253(75%) | ||
Paternal ethnicity | Asian | 20 (3%) | 12 (2%) | 8 (2%) | 0.108 |
Black | 187 (26%) | 101 (26%) | 86 (26%) | ||
American Indian or Alaskan Native | 5 (1%) | 5 (1%) | |||
White | 499 (69%) | 265 (69%) | 234 (70%) |
*P values are based on Fisher’s exact test for categorical variables and Kruskal–Wallis test for continuous variables.
. | Total . | Males . | Females . | . | |
---|---|---|---|---|---|
. | . | n (%/SD) . | n (%/SD) . | n (%/SD) . | P value* . |
Sample size | 722 | 386 (53%) | 336 (47%) | ||
Mean gestational age (days) | 260.77 (19.62) | 260.54 (19.5) | 261.04 (19.78) | 0.614 | |
Mean birthweight in grams | 2831.43 (710.96) | 2877.92 (716.47) | 2778.01 (701.86) | 0.074 | |
Maternal age | 29.83 (5.85) | 29.73 (5.76) | 29.95 (5.97) | 0.512 | |
Paternal age | 32.41 (6.75) | 32.17 (6.7) | 32.68 (6.81) | 0.369 | |
Singletons/twins | 367/355 | 196/190 | 171/165 | 0.694 | |
Total family income | Low | 277 (38%) | 148 (38%) | 129 (38%) | 0.375 |
Medium | 339 (47%) | 183 (47%) | 156 (46%) | ||
High | 63 (9%) | 28 (7%) | 35 (10%) | ||
Maternal education | Secondary | 227 (31%) | 119 (31%) | 108 (32%) | 0.748 |
Tertiary | 494 (68%) | 266 (69%) | 228 (68%) | ||
Paternal education | Primary | 1 | 1 | 0.271 | |
Secondary | 257 (36%) | 130 (34%) | 127 (38%) | ||
Tertiary | 439 (61%) | 240 (62%) | 199 (59%) | ||
Maternal ethnicity | Asian | 13 (2%) | 11 (3%) | 2 (1%) | 0.028 |
Black | 170 (24%) | 89 (23%) | 81 (24%) | ||
American Indian or Alaskan Native | 4 (1%) | 4 (1%) | 0 | ||
White | 535 (74%) | 282 (73%) | 253(75%) | ||
Paternal ethnicity | Asian | 20 (3%) | 12 (2%) | 8 (2%) | 0.108 |
Black | 187 (26%) | 101 (26%) | 86 (26%) | ||
American Indian or Alaskan Native | 5 (1%) | 5 (1%) | |||
White | 499 (69%) | 265 (69%) | 234 (70%) |
. | Total . | Males . | Females . | . | |
---|---|---|---|---|---|
. | . | n (%/SD) . | n (%/SD) . | n (%/SD) . | P value* . |
Sample size | 722 | 386 (53%) | 336 (47%) | ||
Mean gestational age (days) | 260.77 (19.62) | 260.54 (19.5) | 261.04 (19.78) | 0.614 | |
Mean birthweight in grams | 2831.43 (710.96) | 2877.92 (716.47) | 2778.01 (701.86) | 0.074 | |
Maternal age | 29.83 (5.85) | 29.73 (5.76) | 29.95 (5.97) | 0.512 | |
Paternal age | 32.41 (6.75) | 32.17 (6.7) | 32.68 (6.81) | 0.369 | |
Singletons/twins | 367/355 | 196/190 | 171/165 | 0.694 | |
Total family income | Low | 277 (38%) | 148 (38%) | 129 (38%) | 0.375 |
Medium | 339 (47%) | 183 (47%) | 156 (46%) | ||
High | 63 (9%) | 28 (7%) | 35 (10%) | ||
Maternal education | Secondary | 227 (31%) | 119 (31%) | 108 (32%) | 0.748 |
Tertiary | 494 (68%) | 266 (69%) | 228 (68%) | ||
Paternal education | Primary | 1 | 1 | 0.271 | |
Secondary | 257 (36%) | 130 (34%) | 127 (38%) | ||
Tertiary | 439 (61%) | 240 (62%) | 199 (59%) | ||
Maternal ethnicity | Asian | 13 (2%) | 11 (3%) | 2 (1%) | 0.028 |
Black | 170 (24%) | 89 (23%) | 81 (24%) | ||
American Indian or Alaskan Native | 4 (1%) | 4 (1%) | 0 | ||
White | 535 (74%) | 282 (73%) | 253(75%) | ||
Paternal ethnicity | Asian | 20 (3%) | 12 (2%) | 8 (2%) | 0.108 |
Black | 187 (26%) | 101 (26%) | 86 (26%) | ||
American Indian or Alaskan Native | 5 (1%) | 5 (1%) | |||
White | 499 (69%) | 265 (69%) | 234 (70%) |
*P values are based on Fisher’s exact test for categorical variables and Kruskal–Wallis test for continuous variables.
Table 2 includes the descriptive statistics for predictor and outcome variables between males and females in the study sample. Salivary testosterone levels were higher in males than females, but the difference was not statistically significant (P value = 0.062). The correlation of salivary–serum testosterone levels is known to be higher for males than females (Shirtcliff et al. 2002) such that the predicted average serum testosterone value for males in our sample is 2.33 as opposed to 0.36 in our females. The mean number of CAG repeats in both males and females was similar. In general, the digit ratios were lower in males compared with females. Sex was a significant predictor for digit ratios in right- (P value = 0.04) and left (P value = 0.001) hand after controlling for age and maternal ethnicity. Age was not a significant factor in predicting digit ratio in this study (Supplementary Figs 1 and 2). Correlation matrix of the predictor variables is given as Supplementary Figure 3. Total surface area was larger in males when compared with females (Fig. 1). Age, sex, and their interaction were significant contributors in determining total surface area after controlling for birthweight, gestational age, and maternal ethnicity (P value <0.001) (Fig. 2) (Supplementary Table 2).
Descriptive statistics of salivary testosterone, mean CAG repeat length, digit ratios, and brain surface area by sex
Variable . | Total mean (SD) . | Males . | Females . | P values* . |
---|---|---|---|---|
Testosterone | 40.98(15.23) | 42.02(14.99) | 39.72(15.46) | 0.062 |
CAG repeats | 19.51(2.7) | 19.55(3.04) | 19.47(2.28) | 0.919 |
R2R4 Y0 | 0.93(0.04) | 0.93(0.04) | 0.94(0.04) | 0.007 |
L2L4 Y0 | 0.93(0.04) | 0.92(0.04) | 0.93(0.04) | 0.0126 |
R2R4 Y1 | 0.92(0.05) | 0.92(0.05) | 0.93(0.06) | 0.22 |
L2L4 Y1 | 0.92(0.04) | 0.91(0.04) | 0.92(0.05) | 0.156 |
R2R4 Y2 | 0.93(0.05) | 0.93(0.04) | 0.94(0.05) | 0.024 |
L2L4 Y2 | 0.93(0.04) | 0.93(0.04) | 0.93(0.04) | 0.191 |
TSA Y0 | 79055.61 (9385.34) | 80785.79 (9055.76) | 77012.51 (9372.43) | <0.001 |
TSA Y1 | 142 188 (13567.31) | 147731.7 (11845.78) | 136193.9 (12760.15) | <0.001 |
TSA Y2 | 168873.3 (15229.91) | 173826.4 (13663.08) | 162637.4 (14846.96) | <0.001 |
Variable . | Total mean (SD) . | Males . | Females . | P values* . |
---|---|---|---|---|
Testosterone | 40.98(15.23) | 42.02(14.99) | 39.72(15.46) | 0.062 |
CAG repeats | 19.51(2.7) | 19.55(3.04) | 19.47(2.28) | 0.919 |
R2R4 Y0 | 0.93(0.04) | 0.93(0.04) | 0.94(0.04) | 0.007 |
L2L4 Y0 | 0.93(0.04) | 0.92(0.04) | 0.93(0.04) | 0.0126 |
R2R4 Y1 | 0.92(0.05) | 0.92(0.05) | 0.93(0.06) | 0.22 |
L2L4 Y1 | 0.92(0.04) | 0.91(0.04) | 0.92(0.05) | 0.156 |
R2R4 Y2 | 0.93(0.05) | 0.93(0.04) | 0.94(0.05) | 0.024 |
L2L4 Y2 | 0.93(0.04) | 0.93(0.04) | 0.93(0.04) | 0.191 |
TSA Y0 | 79055.61 (9385.34) | 80785.79 (9055.76) | 77012.51 (9372.43) | <0.001 |
TSA Y1 | 142 188 (13567.31) | 147731.7 (11845.78) | 136193.9 (12760.15) | <0.001 |
TSA Y2 | 168873.3 (15229.91) | 173826.4 (13663.08) | 162637.4 (14846.96) | <0.001 |
*P values are based on linear mixed models controlled for maternal ethnicity. Age and transferrin levels were also controlled for in the analysis of salivary testosterone. Visit age, birthweight, and gestational age were controlled for in the analysis of total surface area.
Descriptive statistics of salivary testosterone, mean CAG repeat length, digit ratios, and brain surface area by sex
Variable . | Total mean (SD) . | Males . | Females . | P values* . |
---|---|---|---|---|
Testosterone | 40.98(15.23) | 42.02(14.99) | 39.72(15.46) | 0.062 |
CAG repeats | 19.51(2.7) | 19.55(3.04) | 19.47(2.28) | 0.919 |
R2R4 Y0 | 0.93(0.04) | 0.93(0.04) | 0.94(0.04) | 0.007 |
L2L4 Y0 | 0.93(0.04) | 0.92(0.04) | 0.93(0.04) | 0.0126 |
R2R4 Y1 | 0.92(0.05) | 0.92(0.05) | 0.93(0.06) | 0.22 |
L2L4 Y1 | 0.92(0.04) | 0.91(0.04) | 0.92(0.05) | 0.156 |
R2R4 Y2 | 0.93(0.05) | 0.93(0.04) | 0.94(0.05) | 0.024 |
L2L4 Y2 | 0.93(0.04) | 0.93(0.04) | 0.93(0.04) | 0.191 |
TSA Y0 | 79055.61 (9385.34) | 80785.79 (9055.76) | 77012.51 (9372.43) | <0.001 |
TSA Y1 | 142 188 (13567.31) | 147731.7 (11845.78) | 136193.9 (12760.15) | <0.001 |
TSA Y2 | 168873.3 (15229.91) | 173826.4 (13663.08) | 162637.4 (14846.96) | <0.001 |
Variable . | Total mean (SD) . | Males . | Females . | P values* . |
---|---|---|---|---|
Testosterone | 40.98(15.23) | 42.02(14.99) | 39.72(15.46) | 0.062 |
CAG repeats | 19.51(2.7) | 19.55(3.04) | 19.47(2.28) | 0.919 |
R2R4 Y0 | 0.93(0.04) | 0.93(0.04) | 0.94(0.04) | 0.007 |
L2L4 Y0 | 0.93(0.04) | 0.92(0.04) | 0.93(0.04) | 0.0126 |
R2R4 Y1 | 0.92(0.05) | 0.92(0.05) | 0.93(0.06) | 0.22 |
L2L4 Y1 | 0.92(0.04) | 0.91(0.04) | 0.92(0.05) | 0.156 |
R2R4 Y2 | 0.93(0.05) | 0.93(0.04) | 0.94(0.05) | 0.024 |
L2L4 Y2 | 0.93(0.04) | 0.93(0.04) | 0.93(0.04) | 0.191 |
TSA Y0 | 79055.61 (9385.34) | 80785.79 (9055.76) | 77012.51 (9372.43) | <0.001 |
TSA Y1 | 142 188 (13567.31) | 147731.7 (11845.78) | 136193.9 (12760.15) | <0.001 |
TSA Y2 | 168873.3 (15229.91) | 173826.4 (13663.08) | 162637.4 (14846.96) | <0.001 |
*P values are based on linear mixed models controlled for maternal ethnicity. Age and transferrin levels were also controlled for in the analysis of salivary testosterone. Visit age, birthweight, and gestational age were controlled for in the analysis of total surface area.

Spaghetti plots demonstrating within subject changes over time for surface area.

Age–sex interaction and total surface area. Sex significantly moderates the age-related difference in total surface area. Plot shows quadratic mixed effect regression line for the effect of age at MRI*Sex.
PRS for Testosterone
In females, we observed a significant positive interaction between PRS at the stringent threshold (5 × 10−8) and the linear age term. This association remained significant after multiple corrections (Table 4). PRS for serum testosterone significantly moderated age-related differences in surface area growth in females such that females with high PRS scores showed more surface area expansion from birth to age 2 than females with low PRS scores (Fig. 3). We also observed nominally significant inverse associations between surface area and PRS for testosterone in females at less stringent thresholds (0.01, 0.05, 0.5, and 1) and nominally significant interactions of PRS with age (linear component) at less stringent thresholds (0.05, 0.5, and 1) (Table 3). However, these associations did not survive correction for multiple comparisons. The PRS at various P value thresholds was not significantly associated with total surface area in males. This also remained the case for the interaction term of PRS for testosterone with age in males (Supplementary Table 3). We also tested the interaction of PRS at the stringent threshold for testosterone with sex and age to confirm sex-specific effects. The results were statistically significant for the interaction of PRS with sex and the linear age term (Supplementary Table 4).

PRS testosterone–age interaction and total surface area. PRS for serum testosterone significantly moderated age-related differences in surface area growth in females. Plot shows quadratic mixed effect regression line for the effect of PRS at threshold 5 × 10−8 with age. modx_group shows the values for PRS for which the lines are plotted. Actual data points are plotted as scatterplot on top of the interaction lines and the color of the dots are based on the PRS scores of the subjects.
Regression results of testing the effect of PRS for serum testosterone and total surface area in females
Predictors . | Estimates . | SE . | Std. Beta . | Standardized SE . | Standardized CI . | Statistic . | P * . | Number of SNPs . |
---|---|---|---|---|---|---|---|---|
Main effect | ||||||||
5*10−8 | 1127320.85 | 892343.65 | 0.02 | 0.02 | −0.01—0.06 | 1.26 | 0.206 | 84 |
0.001 | −354207.1 | 8332570.19 | 0 | 0.02 | −0.04—0.03 | −0.04 | 0.966 | 1917 |
0.01 | −50 883 254 | 22447030.5 | −0.04 | 0.02 | −0.08—−0.01 | −2.27 | 0.023* | 9808 |
0.05 | −105 906 398 | 44735865.3 | −0.04 | 0.02 | −0.08—−0.01 | −2.37 | 0.018* | 32 467 |
0.5 | −367 182 317 | 141 164 366 | −0.05 | 0.02 | −0.08—−0.01 | −2.6 | 0.009* | 164 249 |
1 | −477 743 843 | 191 461 063 | −0.05 | 0.02 | −0.08 – −0.01 | −2.5 | 0.013* | 230 215 |
Interaction with age (linear term) | ||||||||
5*10−8 | 35106253.42 | 9758461.83 | 0.7 | 0.19 | 0.32–1.08 | 3.6 | <0.001** | 84 |
0.001 | 46762013.06 | 104 969 673 | 0.1 | 0.22 | −0.33– 0.52 | 0.45 | 0.656 | 1917 |
0.01 | −465 262 904 | 277 494 893 | −0.36 | 0.22 | −0.79– 0.06 | −1.68 | 0.094 | 9808 |
0.05 | −1 141 413 442 | 507 680 927 | −0.44 | 0.2 | −0.83 – −0.06 | −2.25 | 0.025* | 32 467 |
0.5 | −4 795 299 290 | 1 615 227 570 | −0.59 | 0.2 | −0.98 – −0.20 | −2.97 | 0.003* | 164 249 |
1 | −6 190 370 444 | 2 179 198 099 | −0.57 | 0.2 | −0.96 – −0.17 | −2.84 | 0.005* | 230 215 |
Interaction with age (quadratic term) | ||||||||
5*10−8 | 296415.22 | 9193904.88 | 0.01 | 0.19 | −0.36– 0.37 | 0.03 | 0.974 | 84 |
0.001 | 13222079.3 | 92336579.3 | 0.03 | 0.19 | −0.35– 0.40 | 0.14 | 0.886 | 1917 |
0.01 | −97 506 765 | 235 388 392 | −0.08 | 0.19 | −0.44– 0.29 | −0.41 | 0.679 | 9808 |
0.05 | 402739260.5 | 477 674 540 | 0.16 | 0.19 | −0.21– 0.53 | 0.84 | 0.399 | 32 467 |
0.5 | 1 584 337 524 | 1 497 253 898 | 0.2 | 0.19 | −0.17– 0.56 | 1.06 | 0.29 | 164 249 |
1 | 2 113 042 144 | 2 026 616 501 | 0.2 | 0.19 | −0.17– 0.56 | 1.04 | 0.297 | 230 215 |
N | 188id | |||||||
153twinid | ||||||||
Observations | 343 |
Predictors . | Estimates . | SE . | Std. Beta . | Standardized SE . | Standardized CI . | Statistic . | P * . | Number of SNPs . |
---|---|---|---|---|---|---|---|---|
Main effect | ||||||||
5*10−8 | 1127320.85 | 892343.65 | 0.02 | 0.02 | −0.01—0.06 | 1.26 | 0.206 | 84 |
0.001 | −354207.1 | 8332570.19 | 0 | 0.02 | −0.04—0.03 | −0.04 | 0.966 | 1917 |
0.01 | −50 883 254 | 22447030.5 | −0.04 | 0.02 | −0.08—−0.01 | −2.27 | 0.023* | 9808 |
0.05 | −105 906 398 | 44735865.3 | −0.04 | 0.02 | −0.08—−0.01 | −2.37 | 0.018* | 32 467 |
0.5 | −367 182 317 | 141 164 366 | −0.05 | 0.02 | −0.08—−0.01 | −2.6 | 0.009* | 164 249 |
1 | −477 743 843 | 191 461 063 | −0.05 | 0.02 | −0.08 – −0.01 | −2.5 | 0.013* | 230 215 |
Interaction with age (linear term) | ||||||||
5*10−8 | 35106253.42 | 9758461.83 | 0.7 | 0.19 | 0.32–1.08 | 3.6 | <0.001** | 84 |
0.001 | 46762013.06 | 104 969 673 | 0.1 | 0.22 | −0.33– 0.52 | 0.45 | 0.656 | 1917 |
0.01 | −465 262 904 | 277 494 893 | −0.36 | 0.22 | −0.79– 0.06 | −1.68 | 0.094 | 9808 |
0.05 | −1 141 413 442 | 507 680 927 | −0.44 | 0.2 | −0.83 – −0.06 | −2.25 | 0.025* | 32 467 |
0.5 | −4 795 299 290 | 1 615 227 570 | −0.59 | 0.2 | −0.98 – −0.20 | −2.97 | 0.003* | 164 249 |
1 | −6 190 370 444 | 2 179 198 099 | −0.57 | 0.2 | −0.96 – −0.17 | −2.84 | 0.005* | 230 215 |
Interaction with age (quadratic term) | ||||||||
5*10−8 | 296415.22 | 9193904.88 | 0.01 | 0.19 | −0.36– 0.37 | 0.03 | 0.974 | 84 |
0.001 | 13222079.3 | 92336579.3 | 0.03 | 0.19 | −0.35– 0.40 | 0.14 | 0.886 | 1917 |
0.01 | −97 506 765 | 235 388 392 | −0.08 | 0.19 | −0.44– 0.29 | −0.41 | 0.679 | 9808 |
0.05 | 402739260.5 | 477 674 540 | 0.16 | 0.19 | −0.21– 0.53 | 0.84 | 0.399 | 32 467 |
0.5 | 1 584 337 524 | 1 497 253 898 | 0.2 | 0.19 | −0.17– 0.56 | 1.06 | 0.29 | 164 249 |
1 | 2 113 042 144 | 2 026 616 501 | 0.2 | 0.19 | −0.17– 0.56 | 1.04 | 0.297 | 230 215 |
N | 188id | |||||||
153twinid | ||||||||
Observations | 343 |
*P value <0.05 “*” and <0.002 “**” (P value for significance after correction for multiple comparison).
Regression results of testing the effect of PRS for serum testosterone and total surface area in females
Predictors . | Estimates . | SE . | Std. Beta . | Standardized SE . | Standardized CI . | Statistic . | P * . | Number of SNPs . |
---|---|---|---|---|---|---|---|---|
Main effect | ||||||||
5*10−8 | 1127320.85 | 892343.65 | 0.02 | 0.02 | −0.01—0.06 | 1.26 | 0.206 | 84 |
0.001 | −354207.1 | 8332570.19 | 0 | 0.02 | −0.04—0.03 | −0.04 | 0.966 | 1917 |
0.01 | −50 883 254 | 22447030.5 | −0.04 | 0.02 | −0.08—−0.01 | −2.27 | 0.023* | 9808 |
0.05 | −105 906 398 | 44735865.3 | −0.04 | 0.02 | −0.08—−0.01 | −2.37 | 0.018* | 32 467 |
0.5 | −367 182 317 | 141 164 366 | −0.05 | 0.02 | −0.08—−0.01 | −2.6 | 0.009* | 164 249 |
1 | −477 743 843 | 191 461 063 | −0.05 | 0.02 | −0.08 – −0.01 | −2.5 | 0.013* | 230 215 |
Interaction with age (linear term) | ||||||||
5*10−8 | 35106253.42 | 9758461.83 | 0.7 | 0.19 | 0.32–1.08 | 3.6 | <0.001** | 84 |
0.001 | 46762013.06 | 104 969 673 | 0.1 | 0.22 | −0.33– 0.52 | 0.45 | 0.656 | 1917 |
0.01 | −465 262 904 | 277 494 893 | −0.36 | 0.22 | −0.79– 0.06 | −1.68 | 0.094 | 9808 |
0.05 | −1 141 413 442 | 507 680 927 | −0.44 | 0.2 | −0.83 – −0.06 | −2.25 | 0.025* | 32 467 |
0.5 | −4 795 299 290 | 1 615 227 570 | −0.59 | 0.2 | −0.98 – −0.20 | −2.97 | 0.003* | 164 249 |
1 | −6 190 370 444 | 2 179 198 099 | −0.57 | 0.2 | −0.96 – −0.17 | −2.84 | 0.005* | 230 215 |
Interaction with age (quadratic term) | ||||||||
5*10−8 | 296415.22 | 9193904.88 | 0.01 | 0.19 | −0.36– 0.37 | 0.03 | 0.974 | 84 |
0.001 | 13222079.3 | 92336579.3 | 0.03 | 0.19 | −0.35– 0.40 | 0.14 | 0.886 | 1917 |
0.01 | −97 506 765 | 235 388 392 | −0.08 | 0.19 | −0.44– 0.29 | −0.41 | 0.679 | 9808 |
0.05 | 402739260.5 | 477 674 540 | 0.16 | 0.19 | −0.21– 0.53 | 0.84 | 0.399 | 32 467 |
0.5 | 1 584 337 524 | 1 497 253 898 | 0.2 | 0.19 | −0.17– 0.56 | 1.06 | 0.29 | 164 249 |
1 | 2 113 042 144 | 2 026 616 501 | 0.2 | 0.19 | −0.17– 0.56 | 1.04 | 0.297 | 230 215 |
N | 188id | |||||||
153twinid | ||||||||
Observations | 343 |
Predictors . | Estimates . | SE . | Std. Beta . | Standardized SE . | Standardized CI . | Statistic . | P * . | Number of SNPs . |
---|---|---|---|---|---|---|---|---|
Main effect | ||||||||
5*10−8 | 1127320.85 | 892343.65 | 0.02 | 0.02 | −0.01—0.06 | 1.26 | 0.206 | 84 |
0.001 | −354207.1 | 8332570.19 | 0 | 0.02 | −0.04—0.03 | −0.04 | 0.966 | 1917 |
0.01 | −50 883 254 | 22447030.5 | −0.04 | 0.02 | −0.08—−0.01 | −2.27 | 0.023* | 9808 |
0.05 | −105 906 398 | 44735865.3 | −0.04 | 0.02 | −0.08—−0.01 | −2.37 | 0.018* | 32 467 |
0.5 | −367 182 317 | 141 164 366 | −0.05 | 0.02 | −0.08—−0.01 | −2.6 | 0.009* | 164 249 |
1 | −477 743 843 | 191 461 063 | −0.05 | 0.02 | −0.08 – −0.01 | −2.5 | 0.013* | 230 215 |
Interaction with age (linear term) | ||||||||
5*10−8 | 35106253.42 | 9758461.83 | 0.7 | 0.19 | 0.32–1.08 | 3.6 | <0.001** | 84 |
0.001 | 46762013.06 | 104 969 673 | 0.1 | 0.22 | −0.33– 0.52 | 0.45 | 0.656 | 1917 |
0.01 | −465 262 904 | 277 494 893 | −0.36 | 0.22 | −0.79– 0.06 | −1.68 | 0.094 | 9808 |
0.05 | −1 141 413 442 | 507 680 927 | −0.44 | 0.2 | −0.83 – −0.06 | −2.25 | 0.025* | 32 467 |
0.5 | −4 795 299 290 | 1 615 227 570 | −0.59 | 0.2 | −0.98 – −0.20 | −2.97 | 0.003* | 164 249 |
1 | −6 190 370 444 | 2 179 198 099 | −0.57 | 0.2 | −0.96 – −0.17 | −2.84 | 0.005* | 230 215 |
Interaction with age (quadratic term) | ||||||||
5*10−8 | 296415.22 | 9193904.88 | 0.01 | 0.19 | −0.36– 0.37 | 0.03 | 0.974 | 84 |
0.001 | 13222079.3 | 92336579.3 | 0.03 | 0.19 | −0.35– 0.40 | 0.14 | 0.886 | 1917 |
0.01 | −97 506 765 | 235 388 392 | −0.08 | 0.19 | −0.44– 0.29 | −0.41 | 0.679 | 9808 |
0.05 | 402739260.5 | 477 674 540 | 0.16 | 0.19 | −0.21– 0.53 | 0.84 | 0.399 | 32 467 |
0.5 | 1 584 337 524 | 1 497 253 898 | 0.2 | 0.19 | −0.17– 0.56 | 1.06 | 0.29 | 164 249 |
1 | 2 113 042 144 | 2 026 616 501 | 0.2 | 0.19 | −0.17– 0.56 | 1.04 | 0.297 | 230 215 |
N | 188id | |||||||
153twinid | ||||||||
Observations | 343 |
*P value <0.05 “*” and <0.002 “**” (P value for significance after correction for multiple comparison).
Salivary Testosterone
The effect of testosterone in minipuberty was assessed using salivary testosterone levels at 3 months. We did not observe any association between the testosterone levels or their interaction with age (Table 4) and total surface area in infancy in either males or females. We tested if the change in surface area from 1 to 12 months was associated with testosterone levels during the minipuberty. We found a nominally significant association between the testosterone levels and change in surface area in females. However, this association does not withstand correction for multiple comparisons.
Regression results of testing the effect of salivary testosterone on total surface area
Predictors . | Estimates . | SE . | Std. Beta . | Standardized SE . | Standardized CI . | Statistic . | P * . |
---|---|---|---|---|---|---|---|
Males (N = 160 id; 122 twinid; Observations = 306) | |||||||
Testosterone | 12.41 | 53.01 | 0.00 | 0.02 | −0.03– 0.04 | 0.23 | 0.815 |
Testosterone: age (linear) | 121.86 | 520.48 | 0.05 | 0.19 | −0.32– 0.42 | 0.23 | 0.815 |
Testosterone: age (quadratic) | 248.65 | 493.50 | 0.09 | 0.18 | −0.27– 0.45 | 0.50 | 0.614 |
Females (N = 131 id; 103 twinid; Observations = 255) | |||||||
Testosterone | −85.97 | 60.40 | −0.03 | 0.02 | −0.08– 0.01 | −1.42 | 0.155 |
Testosterone: age (linear) | −476.88 | 542.68 | −0.17 | 0.20 | −0.571– 0.23 | −0.88 | 0.38 |
Testosterone: age (quadratic) | 469.84 | 490.05 | 0.18 | 0.19 | −0.19– 0.55 | 0.96 | 0.338 |
Effect of salivary testosterone on change of surface area from birth to year 1 | |||||||
Males (N = 68 twinid; Observations = 89) | |||||||
Testosterone | 4.66 | 78.64 | 0.01 | 0.11 | −0.2 – 0.21 | 0.06 | 0.953 |
Females (N = 59 twinid; Observations = 72) | |||||||
Testosterone | −142.91 | 69.09 | −0.19 | 0.09 | −0.38 – −0.01 | −2.07 | 0.039* |
Predictors . | Estimates . | SE . | Std. Beta . | Standardized SE . | Standardized CI . | Statistic . | P * . |
---|---|---|---|---|---|---|---|
Males (N = 160 id; 122 twinid; Observations = 306) | |||||||
Testosterone | 12.41 | 53.01 | 0.00 | 0.02 | −0.03– 0.04 | 0.23 | 0.815 |
Testosterone: age (linear) | 121.86 | 520.48 | 0.05 | 0.19 | −0.32– 0.42 | 0.23 | 0.815 |
Testosterone: age (quadratic) | 248.65 | 493.50 | 0.09 | 0.18 | −0.27– 0.45 | 0.50 | 0.614 |
Females (N = 131 id; 103 twinid; Observations = 255) | |||||||
Testosterone | −85.97 | 60.40 | −0.03 | 0.02 | −0.08– 0.01 | −1.42 | 0.155 |
Testosterone: age (linear) | −476.88 | 542.68 | −0.17 | 0.20 | −0.571– 0.23 | −0.88 | 0.38 |
Testosterone: age (quadratic) | 469.84 | 490.05 | 0.18 | 0.19 | −0.19– 0.55 | 0.96 | 0.338 |
Effect of salivary testosterone on change of surface area from birth to year 1 | |||||||
Males (N = 68 twinid; Observations = 89) | |||||||
Testosterone | 4.66 | 78.64 | 0.01 | 0.11 | −0.2 – 0.21 | 0.06 | 0.953 |
Females (N = 59 twinid; Observations = 72) | |||||||
Testosterone | −142.91 | 69.09 | −0.19 | 0.09 | −0.38 – −0.01 | −2.07 | 0.039* |
*P value <0.05 “*” and <0.002 “**” (P value for significance after correction for multiple comparison).
Regression results of testing the effect of salivary testosterone on total surface area
Predictors . | Estimates . | SE . | Std. Beta . | Standardized SE . | Standardized CI . | Statistic . | P * . |
---|---|---|---|---|---|---|---|
Males (N = 160 id; 122 twinid; Observations = 306) | |||||||
Testosterone | 12.41 | 53.01 | 0.00 | 0.02 | −0.03– 0.04 | 0.23 | 0.815 |
Testosterone: age (linear) | 121.86 | 520.48 | 0.05 | 0.19 | −0.32– 0.42 | 0.23 | 0.815 |
Testosterone: age (quadratic) | 248.65 | 493.50 | 0.09 | 0.18 | −0.27– 0.45 | 0.50 | 0.614 |
Females (N = 131 id; 103 twinid; Observations = 255) | |||||||
Testosterone | −85.97 | 60.40 | −0.03 | 0.02 | −0.08– 0.01 | −1.42 | 0.155 |
Testosterone: age (linear) | −476.88 | 542.68 | −0.17 | 0.20 | −0.571– 0.23 | −0.88 | 0.38 |
Testosterone: age (quadratic) | 469.84 | 490.05 | 0.18 | 0.19 | −0.19– 0.55 | 0.96 | 0.338 |
Effect of salivary testosterone on change of surface area from birth to year 1 | |||||||
Males (N = 68 twinid; Observations = 89) | |||||||
Testosterone | 4.66 | 78.64 | 0.01 | 0.11 | −0.2 – 0.21 | 0.06 | 0.953 |
Females (N = 59 twinid; Observations = 72) | |||||||
Testosterone | −142.91 | 69.09 | −0.19 | 0.09 | −0.38 – −0.01 | −2.07 | 0.039* |
Predictors . | Estimates . | SE . | Std. Beta . | Standardized SE . | Standardized CI . | Statistic . | P * . |
---|---|---|---|---|---|---|---|
Males (N = 160 id; 122 twinid; Observations = 306) | |||||||
Testosterone | 12.41 | 53.01 | 0.00 | 0.02 | −0.03– 0.04 | 0.23 | 0.815 |
Testosterone: age (linear) | 121.86 | 520.48 | 0.05 | 0.19 | −0.32– 0.42 | 0.23 | 0.815 |
Testosterone: age (quadratic) | 248.65 | 493.50 | 0.09 | 0.18 | −0.27– 0.45 | 0.50 | 0.614 |
Females (N = 131 id; 103 twinid; Observations = 255) | |||||||
Testosterone | −85.97 | 60.40 | −0.03 | 0.02 | −0.08– 0.01 | −1.42 | 0.155 |
Testosterone: age (linear) | −476.88 | 542.68 | −0.17 | 0.20 | −0.571– 0.23 | −0.88 | 0.38 |
Testosterone: age (quadratic) | 469.84 | 490.05 | 0.18 | 0.19 | −0.19– 0.55 | 0.96 | 0.338 |
Effect of salivary testosterone on change of surface area from birth to year 1 | |||||||
Males (N = 68 twinid; Observations = 89) | |||||||
Testosterone | 4.66 | 78.64 | 0.01 | 0.11 | −0.2 – 0.21 | 0.06 | 0.953 |
Females (N = 59 twinid; Observations = 72) | |||||||
Testosterone | −142.91 | 69.09 | −0.19 | 0.09 | −0.38 – −0.01 | −2.07 | 0.039* |
*P value <0.05 “*” and <0.002 “**” (P value for significance after correction for multiple comparison).
CAG Repeats
To assess the effect of sensitivity of androgen receptors (AR) on surface area development, we investigated the role of a polymorphic nucleotide repeat (CAG). There was no significant relationship between the length of the CAG repeats and total surface area development in males and females. The interaction of CAG repeat with the linear term of age variable was nominally significant in males (Table 5). However, this association does not withstand correction for multiple comparisons.
Regression results of testing the effect of number of CAG repeats and total surface area
Predictors . | Estimates . | SE . | Std. Beta . | Standardized SE . | Standardized CI . | Statistic . | P * . |
---|---|---|---|---|---|---|---|
Males (N = 210; 169 twinid; Observations = 396) | |||||||
CAGrepeat | 32.32 | 246.86 | 0.00 | 0.02 | −0.03– 0.04 | 0.13 | 0.896 |
CAGrepeat: age (linear) | 5656.71 | 2614.84 | 0.39 | 0.18 | 0.04–0.75 | 2.16 | 0.031* |
CAGrepeat: age (quadratic) | −1133.32 | 2473.77 | −0.08 | 0.18 | −0.43– 0.27 | −0.46 | 0.647 |
Females (N = 191; 150 twinid; Observations = 363) | |||||||
CAGrepeat | −100.65 | 339.58 | −0.01 | 0.02 | −0.04– 0.03 | −0.30 | 0.767 |
CAGrepeat: age (linear) | 4809.25 | 3440.29 | 0.27 | 0.20 | −0.12– 0.66 | 1.40 | 0.162 |
CAGrepeat: age (quadratic) | −4413.30 | 3412.23 | −0.26 | 0.20 | −0.64– 0.13 | −1.29 | 0.196 |
Predictors . | Estimates . | SE . | Std. Beta . | Standardized SE . | Standardized CI . | Statistic . | P * . |
---|---|---|---|---|---|---|---|
Males (N = 210; 169 twinid; Observations = 396) | |||||||
CAGrepeat | 32.32 | 246.86 | 0.00 | 0.02 | −0.03– 0.04 | 0.13 | 0.896 |
CAGrepeat: age (linear) | 5656.71 | 2614.84 | 0.39 | 0.18 | 0.04–0.75 | 2.16 | 0.031* |
CAGrepeat: age (quadratic) | −1133.32 | 2473.77 | −0.08 | 0.18 | −0.43– 0.27 | −0.46 | 0.647 |
Females (N = 191; 150 twinid; Observations = 363) | |||||||
CAGrepeat | −100.65 | 339.58 | −0.01 | 0.02 | −0.04– 0.03 | −0.30 | 0.767 |
CAGrepeat: age (linear) | 4809.25 | 3440.29 | 0.27 | 0.20 | −0.12– 0.66 | 1.40 | 0.162 |
CAGrepeat: age (quadratic) | −4413.30 | 3412.23 | −0.26 | 0.20 | −0.64– 0.13 | −1.29 | 0.196 |
*P value <0.05 “*” and <0.002 “**” (P value for significance after correction for multiple comparison).
Regression results of testing the effect of number of CAG repeats and total surface area
Predictors . | Estimates . | SE . | Std. Beta . | Standardized SE . | Standardized CI . | Statistic . | P * . |
---|---|---|---|---|---|---|---|
Males (N = 210; 169 twinid; Observations = 396) | |||||||
CAGrepeat | 32.32 | 246.86 | 0.00 | 0.02 | −0.03– 0.04 | 0.13 | 0.896 |
CAGrepeat: age (linear) | 5656.71 | 2614.84 | 0.39 | 0.18 | 0.04–0.75 | 2.16 | 0.031* |
CAGrepeat: age (quadratic) | −1133.32 | 2473.77 | −0.08 | 0.18 | −0.43– 0.27 | −0.46 | 0.647 |
Females (N = 191; 150 twinid; Observations = 363) | |||||||
CAGrepeat | −100.65 | 339.58 | −0.01 | 0.02 | −0.04– 0.03 | −0.30 | 0.767 |
CAGrepeat: age (linear) | 4809.25 | 3440.29 | 0.27 | 0.20 | −0.12– 0.66 | 1.40 | 0.162 |
CAGrepeat: age (quadratic) | −4413.30 | 3412.23 | −0.26 | 0.20 | −0.64– 0.13 | −1.29 | 0.196 |
Predictors . | Estimates . | SE . | Std. Beta . | Standardized SE . | Standardized CI . | Statistic . | P * . |
---|---|---|---|---|---|---|---|
Males (N = 210; 169 twinid; Observations = 396) | |||||||
CAGrepeat | 32.32 | 246.86 | 0.00 | 0.02 | −0.03– 0.04 | 0.13 | 0.896 |
CAGrepeat: age (linear) | 5656.71 | 2614.84 | 0.39 | 0.18 | 0.04–0.75 | 2.16 | 0.031* |
CAGrepeat: age (quadratic) | −1133.32 | 2473.77 | −0.08 | 0.18 | −0.43– 0.27 | −0.46 | 0.647 |
Females (N = 191; 150 twinid; Observations = 363) | |||||||
CAGrepeat | −100.65 | 339.58 | −0.01 | 0.02 | −0.04– 0.03 | −0.30 | 0.767 |
CAGrepeat: age (linear) | 4809.25 | 3440.29 | 0.27 | 0.20 | −0.12– 0.66 | 1.40 | 0.162 |
CAGrepeat: age (quadratic) | −4413.30 | 3412.23 | −0.26 | 0.20 | −0.64– 0.13 | −1.29 | 0.196 |
*P value <0.05 “*” and <0.002 “**” (P value for significance after correction for multiple comparison).
Digit Ratios
To explore the effect of digit ratio on total surface area, we analyzed both right- and left-hand digit ratios separately. There was a nominally significant inverse association between the right-hand digit ratio and surface area in female infants, suggesting that a high ratio of testosterone to estrogen in the prenatal period correlates with greater cortical surface area at birth and throughout infancy (Fig. 4). However, this association did not survive correction for multiple comparisons. The interaction of digit ratio with age was also not significant for either males or females (Table 6). We also tested for the relationship between right–left digit ratio (Dr-l) and cortical surface area. The results were not significant in either males or females (Supplementary Table 5). We also tested the influence of interaction of digit ratio with sex and age in surface area growth to show the sex-specific effects (Supplementary Table 6).

Right-hand digit ratio age interaction and total surface area. Right-hand digit ratio moderates age-related differences in surface area growth in females. Plot shows quadratic mixed effect regression line for the effect of right-hand digit ratio with age. modx_group shows the values for digit ratio for which the lines are plotted. Actual data points are plotted as scatterplot on top of the interaction lines and the color of the dots are based on their right-hand digit ratio of the subjects.
Regression results of testing the effect of digit ratios and total surface area
Predictors . | Estimates . | SE . | Std. Beta . | Standardized SE . | Standardized CI . | Statistic . | P * . |
---|---|---|---|---|---|---|---|
Males (N = 278; 222 twinid; Observations = 387) | |||||||
R2/R4 | −2072.86 | 13302.33 | 0.00 | 0.01 | −0.03– 0.02 | −0.16 | 0.876 |
L2/L4 | 10723.36 | 13225.16 | 0.01 | 0.01 | −0.01– 0.04 | 0.81 | 0.417 |
Interaction with age (linear term) | |||||||
R2/R4:age (linear) | 24797.96 | 246551.86 | 0.01 | 0.24 | −0.45– 0.48 | 0.10 | 0.92 |
L2/L4:age (linear) | 323563.71 | 257849.07 | 0.30 | 0.23 | −0.16– 0.76 | 1.25 | 0.21 |
Interaction with age (quadratic term) | |||||||
R2/R4:age (quadratic) | −265400.82 | 244393.14 | −0.26 | 0.24 | −0.73– 0.21 | −1.09 | 0.277 |
L2/L4:age (quadratic) | 93638.27 | 256261.68 | 0.09 | 0.24 | −0.38– 0.55 | 0.37 | 0.715 |
Females (N = 237;187 twinid; Observations = 339) | |||||||
R2/R4 | −42040.74 | 13926.49 | −0.05 | 0.02 | −0.08 – −0.02 | −3.02 | 0.003* |
L2/L4 | 2264.39 | 13365.29 | 0.00 | 0.01 | −0.03– 0.03 | 0.17 | 0.865 |
Interaction with age (linear term) | |||||||
R2/R4:age (linear) | −233487.13 | 247570.22 | −0.25 | 0.26 | −0.76– 0.27 | −0.94 | 0.346 |
L2/L4:age (linear) | 178959.41 | 256496.01 | 0.18 | 0.28 | −0.36– 0.72 | 0.70 | 0.485 |
Interaction with age (quadratic term) | |||||||
R2/R4:age (quadratic) | 47652.64 | 242929.51 | 0.05 | 0.26 | −0.47– 0.57 | 0.20 | 0.844 |
L2/L4:age (quadratic) | −272510.82 | 241978.83 | −0.30 | 0.27 | −0.82– 0.22 | −1.13 | 0.26 |
Predictors . | Estimates . | SE . | Std. Beta . | Standardized SE . | Standardized CI . | Statistic . | P * . |
---|---|---|---|---|---|---|---|
Males (N = 278; 222 twinid; Observations = 387) | |||||||
R2/R4 | −2072.86 | 13302.33 | 0.00 | 0.01 | −0.03– 0.02 | −0.16 | 0.876 |
L2/L4 | 10723.36 | 13225.16 | 0.01 | 0.01 | −0.01– 0.04 | 0.81 | 0.417 |
Interaction with age (linear term) | |||||||
R2/R4:age (linear) | 24797.96 | 246551.86 | 0.01 | 0.24 | −0.45– 0.48 | 0.10 | 0.92 |
L2/L4:age (linear) | 323563.71 | 257849.07 | 0.30 | 0.23 | −0.16– 0.76 | 1.25 | 0.21 |
Interaction with age (quadratic term) | |||||||
R2/R4:age (quadratic) | −265400.82 | 244393.14 | −0.26 | 0.24 | −0.73– 0.21 | −1.09 | 0.277 |
L2/L4:age (quadratic) | 93638.27 | 256261.68 | 0.09 | 0.24 | −0.38– 0.55 | 0.37 | 0.715 |
Females (N = 237;187 twinid; Observations = 339) | |||||||
R2/R4 | −42040.74 | 13926.49 | −0.05 | 0.02 | −0.08 – −0.02 | −3.02 | 0.003* |
L2/L4 | 2264.39 | 13365.29 | 0.00 | 0.01 | −0.03– 0.03 | 0.17 | 0.865 |
Interaction with age (linear term) | |||||||
R2/R4:age (linear) | −233487.13 | 247570.22 | −0.25 | 0.26 | −0.76– 0.27 | −0.94 | 0.346 |
L2/L4:age (linear) | 178959.41 | 256496.01 | 0.18 | 0.28 | −0.36– 0.72 | 0.70 | 0.485 |
Interaction with age (quadratic term) | |||||||
R2/R4:age (quadratic) | 47652.64 | 242929.51 | 0.05 | 0.26 | −0.47– 0.57 | 0.20 | 0.844 |
L2/L4:age (quadratic) | −272510.82 | 241978.83 | −0.30 | 0.27 | −0.82– 0.22 | −1.13 | 0.26 |
*P value <0.05 “*” and <0.002 “**” (P value for significance after correction for multiple comparison).
Regression results of testing the effect of digit ratios and total surface area
Predictors . | Estimates . | SE . | Std. Beta . | Standardized SE . | Standardized CI . | Statistic . | P * . |
---|---|---|---|---|---|---|---|
Males (N = 278; 222 twinid; Observations = 387) | |||||||
R2/R4 | −2072.86 | 13302.33 | 0.00 | 0.01 | −0.03– 0.02 | −0.16 | 0.876 |
L2/L4 | 10723.36 | 13225.16 | 0.01 | 0.01 | −0.01– 0.04 | 0.81 | 0.417 |
Interaction with age (linear term) | |||||||
R2/R4:age (linear) | 24797.96 | 246551.86 | 0.01 | 0.24 | −0.45– 0.48 | 0.10 | 0.92 |
L2/L4:age (linear) | 323563.71 | 257849.07 | 0.30 | 0.23 | −0.16– 0.76 | 1.25 | 0.21 |
Interaction with age (quadratic term) | |||||||
R2/R4:age (quadratic) | −265400.82 | 244393.14 | −0.26 | 0.24 | −0.73– 0.21 | −1.09 | 0.277 |
L2/L4:age (quadratic) | 93638.27 | 256261.68 | 0.09 | 0.24 | −0.38– 0.55 | 0.37 | 0.715 |
Females (N = 237;187 twinid; Observations = 339) | |||||||
R2/R4 | −42040.74 | 13926.49 | −0.05 | 0.02 | −0.08 – −0.02 | −3.02 | 0.003* |
L2/L4 | 2264.39 | 13365.29 | 0.00 | 0.01 | −0.03– 0.03 | 0.17 | 0.865 |
Interaction with age (linear term) | |||||||
R2/R4:age (linear) | −233487.13 | 247570.22 | −0.25 | 0.26 | −0.76– 0.27 | −0.94 | 0.346 |
L2/L4:age (linear) | 178959.41 | 256496.01 | 0.18 | 0.28 | −0.36– 0.72 | 0.70 | 0.485 |
Interaction with age (quadratic term) | |||||||
R2/R4:age (quadratic) | 47652.64 | 242929.51 | 0.05 | 0.26 | −0.47– 0.57 | 0.20 | 0.844 |
L2/L4:age (quadratic) | −272510.82 | 241978.83 | −0.30 | 0.27 | −0.82– 0.22 | −1.13 | 0.26 |
Predictors . | Estimates . | SE . | Std. Beta . | Standardized SE . | Standardized CI . | Statistic . | P * . |
---|---|---|---|---|---|---|---|
Males (N = 278; 222 twinid; Observations = 387) | |||||||
R2/R4 | −2072.86 | 13302.33 | 0.00 | 0.01 | −0.03– 0.02 | −0.16 | 0.876 |
L2/L4 | 10723.36 | 13225.16 | 0.01 | 0.01 | −0.01– 0.04 | 0.81 | 0.417 |
Interaction with age (linear term) | |||||||
R2/R4:age (linear) | 24797.96 | 246551.86 | 0.01 | 0.24 | −0.45– 0.48 | 0.10 | 0.92 |
L2/L4:age (linear) | 323563.71 | 257849.07 | 0.30 | 0.23 | −0.16– 0.76 | 1.25 | 0.21 |
Interaction with age (quadratic term) | |||||||
R2/R4:age (quadratic) | −265400.82 | 244393.14 | −0.26 | 0.24 | −0.73– 0.21 | −1.09 | 0.277 |
L2/L4:age (quadratic) | 93638.27 | 256261.68 | 0.09 | 0.24 | −0.38– 0.55 | 0.37 | 0.715 |
Females (N = 237;187 twinid; Observations = 339) | |||||||
R2/R4 | −42040.74 | 13926.49 | −0.05 | 0.02 | −0.08 – −0.02 | −3.02 | 0.003* |
L2/L4 | 2264.39 | 13365.29 | 0.00 | 0.01 | −0.03– 0.03 | 0.17 | 0.865 |
Interaction with age (linear term) | |||||||
R2/R4:age (linear) | −233487.13 | 247570.22 | −0.25 | 0.26 | −0.76– 0.27 | −0.94 | 0.346 |
L2/L4:age (linear) | 178959.41 | 256496.01 | 0.18 | 0.28 | −0.36– 0.72 | 0.70 | 0.485 |
Interaction with age (quadratic term) | |||||||
R2/R4:age (quadratic) | 47652.64 | 242929.51 | 0.05 | 0.26 | −0.47– 0.57 | 0.20 | 0.844 |
L2/L4:age (quadratic) | −272510.82 | 241978.83 | −0.30 | 0.27 | −0.82– 0.22 | −1.13 | 0.26 |
*P value <0.05 “*” and <0.002 “**” (P value for significance after correction for multiple comparison).
PRS for Estradiol
In our study, we did not observe any significant relationship between PRS for estradiol, or their interaction with age and total surface area in males or females (Supplementary Tables 7 and 8).
Discussion
Although there is substantial overlap in the distributions of males and females, sex differences have been reported for multiple aspects of brain structure. Many of these differences appear to be linked to male–female differences in total brain size (Ritchie et al. 2018). Sex differences in brain size are detectable by midgestation (Studholme et al. 2020), increase throughout infancy, and are accompanied by more rapid expansion of cortical surface area in human males (Gilmore et al. 2018). The mechanisms responsible for these patterns are currently unknown, but many researchers have hypothesized that prenatal and/or early postnatal exposure to gonadal sex steroids might be involved. The current study addressed this question by examining associations between different markers of prenatal and postnatal hormonal exposure and brain surface area in a large, prospective neuroimaging study of human infants. We found that brain surface area in infancy had a positive relationship with the interaction of linear age term and polygenic risk scores for testosterone in females. This relationship remained significant after correction for multiple comparisons. The results suggest testosterone promotes surface area expansion postnatally in females. But this relationship is only observed when we use the PRS derived from SNPs that are most strongly associated with testosterone in adult females. We also observed inverse relationships between PRS at less stringent thresholds and total surface in females. However, these relationships neither survived correction for multiple comparisons nor were they evident when examining other indices of early testosterone effects, namely salivary testosterone measured during the minipuberty and the number of CAG repeats in androgen receptor gene. However, we did observe a nominally significant negative association between salivary testosterone levels and change in surface area from birth to year one. We also observed an inverse relationship between right 2D:4D digit ratio and surface area in females, suggesting that the ratio of testosterone to estrogen might influence cortical development with higher prenatal testosterone level predicting surface area in females. Although this relationship did not survive corrections for multiple comparisons, this is in line with the observation of PRS for testosterone in females, where we saw testosterone promotes surface area expansion. The interaction of digit ratio with age was not significant. The lack of age effects suggests the association of digit ratio reflects prenatal effects, while the positive association of PRS for testosterone interaction with age may reflect the action of postnatal testosterone. PRS for estradiol was not associated with surface area in either males or females. Overall, our results suggest that testosterone exposure may contribute to sex differences in surface area during infancy but plays a greater role in explaining interindividual variation in females than in males. Two questions naturally follow: 1) what cellular and molecular mechanisms might link testosterone exposure to cortical surface area development, and 2) Why did we observe potential relationships in females only?
With regard to question 1, growth of cortical surface area is influenced by genetic (Chen et al. 2013; Jha et al. 2018) and environmental factors (Jha et al. 2019) and shows distinct changes across stages of development (Wierenga et al. 2014; Lyall et al. 2015; Amlien et al. 2016). Prenatally, cortical surface expansion is mainly driven by neurogenesis within columnar units as postulated in Rakic’s radial unit hypothesis (Rakic 1988). Postnatal development is likely shaped by synaptogenesis, gliogenesis, dendritic arborization, and intracortical myelination (Mrzljak et al. 1991; Rakic et al. 1994; Petanjek et al. 2011). Evidence from both mouse and human neural stem cell studies shows that testosterone leads to increased proliferation and neuronal differentiation (Ransome and Boon 2015; Quartier et al. 2018). This is further supported by research in animal models where testosterone was found to influence adult neurogenesis in rodent (Spritzer and Galea 2007) and avian models (Rasika et al. 1994; Barker et al. 2014). Several observational studies in humans also suggest that testosterone may promote cortical expansion. In human males, fetal testosterone levels positively correlated with regional gray matter volume in school-age children (Lombardo et al. 2012), and individuals with congenital adrenal hyperplasia (CAH), who are exposed to high prenatal androgen levels (including testosterone), show increased regional surface area (van’t Westeinde et al. 2020).
With regard to question 2 (why did we observe potential relationships in females only), one possibility is that the proxy measures that showed associations with SA in infant females (PRS for testosterone and right 2D:4D digit ratio) are simply more reliable proxies in females than males. With regard to the PRS scores, it is important to remember that our PRS scores were based on GWAS conducted in adults, as no large-scale GWAS of infant hormone levels are currently available. It is possible that the genetic architecture underlying variation in adult females is similar to that underlying variation in infant females, while the genetic architecture underlying variation in adult males differs from that underlying variation in infant males. We note that the heritability of testosterone levels varies across the lifespan and between males and females (Koenis et al. 2013; Grotzinger, Briley, et al. 2018a). For example, a large twin study in adolescents reported variation in testosterone levels in females is influenced by genetic factors in contrast to males where it is primarily influenced by environmental factors (Van Hulle et al. 2015). However, in most studies, heritability estimates for testosterone are much lower for females compared with males (Meikle et al. 1986; Harris et al. 1998; Pritchard et al. 1998; Hong et al. 2001; Ring et al. 2005; Kuijper et al. 2007; Bogaert et al. 2008; Franks et al. 2008; Harden et al. 2014; Grotzinger, Mann, et al. 2018b). With regard to digit ratios, several studies have reported that amniotic testosterone level is significantly associated with newborn female’s digit ratio only and not with males (Ventura et al. 2013; Richards et al. 2019). In addition, heritability estimates for digit ratio from mother–daughter pairs suggest the trait to be X-linked although this observation is not consistent (Richards et al. 2017). If this is the case, our digit ratio analyses might be capturing an effect of one of more X-chromosome genes on surface area development in females, rather than gonadal steroid effects.
We note that assessing individual variation in gonadal steroid exposure during the prenatal and early postnatal period presents a number of challenges. While testosterone and estradiol can be directly measured in amniotic fluid or in fetal blood, these techniques are medically invasive and usually performed only in high-risk pregnancies. Blood sampling during the minipuberty is certainly possible but may be a recruitment barrier for concerned parents. Consequently, the current study used saliva sampling and a variety of proxy measures to assess exposure including a PRS for serum testosterone, a PRS for serum estradiol, a specific genetic polymorphism in the androgen receptor (AR) gene, and 2D:4D digit ratios. Each of these methods has specific benefits and specific limitations that we will discuss in the following paragraphs.
Salivary measures offer a relatively convenient and noninvasive method for obtaining sex hormone data. These measures represent free, biologically available hormone levels and provide information relevant to neurological and behavioral studies. However, some limitations are known. Although there are reports of strong correlations between serum and salivary testosterone in males (Nahoul et al. 1986; Rilling et al. 1996; Lood et al. 2018), such correlations are significantly lower in females (Granger et al. 1999; Miller et al. 2004). This could potentially underestimate the testosterone-associated phenotypes in females. In our study, we observe a significant relation of surface area with PRS for serum testosterone but only a marginal association for salivary testosterone level in females. The lack of strong correlation between the serum–saliva measures could be a reason for variation in results. Other factors that can significantly influence the salivary testosterone measures include collection methods, blood contamination in saliva, and storage conditions (Granger et al. 2004; Al-DujailI and Sharp 2012). We controlled for all these factors by uniformly collecting samples at fixed time in the morning and samples where frozen in a −80 °C freezer within 4 h of collection. Samples were evaluated for blood contamination by measuring transferrin levels and including them in the analysis. There are more limitations in assessing estradiol levels in children. The levels in saliva are often too low to be reliably measured using immunoassays and also require larger quantities for measurement. The serum–saliva correlations for estradiol are also lower than for other salivary hormones (Shirtcliff et al. 2000; Frederiksen et al. 2020). For these reasons, we did not measure estradiol in our salivary samples.
Polygenic risk scores offer an opportunity to capture interindividual variation in highly dynamic traits like sex hormone levels that are otherwise difficult to capture with single measurements. However, there are some limitations to this approach as it was applied in the context of the current study. First, the base data for PRS generation was summary statistics of GWAS results from UK Biobank samples of unrelated adult individuals of European ancestry (N = 361 194 with 194 174 females and 167 020 males in the age range 40–69 years). The utility of our PRS scores as proxies for prenatal and minipubertal hormone exposure is based on the assumption that there is substantial overlap in the genetic variants involved in sex hormone production during prenatal, minipubertal, and adult stages, as well as their direction of effect. This has not yet been demonstrated empirically as no large-scale GWAS have been conducted for prenatal or minipubertal hormone levels. However, genetic correlations for testosterone between pre- and postmenopausal women in the UK Biobank sample are close to 1.0, suggesting a high degree of stability across the lifespan in females (Flynn et al. 2021). Furthermore, the fact that we observed a significant association between surface area expansion and PRS scores in female infants suggests at least some developmental stability. Nevertheless, we cannot rule out the possibility that our results would have looked different using a PRS score based on infant data, which do not currently exist. Second, although classical twin and family studies show moderate to high heritability for testosterone in adolescence and adulthood, the estimated SNP heritability estimate for testosterone in the UK Biobank sample (n = 312 102 unrelated individuals of European ancestry) was 0.0771, which suggests relatively little variation in testosterone levels can be attributed to common genetic variation (Walters 2020). If variation in prenatal and minipubertal testosterone levels is primarily the result of environmental factors or rare genetic variation, rather than common genetic variation, this would limit to utility of the PRS as a proxy measure for early testosterone exposure. Twin studies conducted during infancy suggest that individual variability in salivary testosterone levels is primarily explained by environmental factors (Caramaschi et al. 2012; Xia et al. 2014), and no genetic effects on testosterone were observed in male and female twins using umbilical cord blood (Sakai et al. 1991). The fact that we observed a significant association between surface area expansion and PRS scores in female infants suggests that common genetic variation does influence testosterone levels in early life, at least in females, though we cannot rule out the possibility that these genetic variants influenced surface area expansion via some other mechanisms (e.g., they may have pleiotropic effects). We also note that the heritability of prenatal testosterone levels has not been tested. Consequently, the association of the testosterone PRS with surface area expansion in females could represent an effect of prenatal testosterone on postnatal development. Finally, heritability of estradiol is much lower than other sex hormones in both men and women and the interindividual variation is mainly attributed to environmental effects (Ring et al. 2005; Stone et al. 2009; Travison et al. 2014). Consequently, the estradiol PRS scores may not have functioned well as proxies for early life estrogen exposure. We cannot rule out the possibility that measuring infant estradiol levels in blood using highly sensitive mass spectrometry–based assays would have revealed relations with surface area development.
The AR receptor polymorphism we examined is a microsatellite trinucleotide (CAG) repeat sequence located in the transactivation domain within the first exon, which encodes a string of 8 to 35 glutamines, depending on the individual. The length of the repeat is inversely associated with the transactivational activity of the AR (Choong and Wilson 1998; Davey and Grossmann 2016) and a more “masculine” pattern of cortical maturation during adolescence (Raznahan et al. 2010). However, CAG repeats alone are not the only factors that influence the AR sensitivity. There are other genetic factors including a polyglycine tract encoded by a polymorphic GGN repeat in exon 1 of the AR (Bogaert et al. 2009; Westberg et al. 2009) and co-activators and co-repressors with tissue-specific effects on AR transactivation (Choong and Wilson 1998; Zitzmann and Nieschlag 2001). Also, there might be compensatory mechanisms increasing circulating testosterone levels in cases where there is a less effective AR (Crabbe et al. 2007; Stanworth et al. 2008). Furthermore, although androgens predominantly exert their biological effects by binding to the androgen receptor (AR) (Heinlein and Chang 2002), they can also exert effects via nongenomic signaling pathways like membrane receptors or by being aromatized to estrogen and acting on estrogen receptors. If these mechanisms are important for testosterone effects on surface area, the CAG repeat would be irrelevant. Finally, the location of the AR on the X-chromosome has important implications when examining effects in females. When calculating the average CAG repeat length in females, we assume random inactivation such that half of female cells are expressing one allele and half are expressing the other allele. However, in reality, X-chromosome inactivation varies between individuals and between tissues and, in some cases, is highly skewed with one X-chromosome being preferentially inactivated. All of these factors could explain why we did not observe an effect of the CAG polymorphism on surface area.
The ratio between lengths of the second and the fourth digits (index and ring fingers) (2D:4D) is a putative biomarker of prenatal testosterone and estrogen exposure (Manning et al. 1998; Altshuler et al. 2010). Digit ratios offer a noninvasive method for estimating prenatal hormonal exposure, may reflect combined effects throughout gestation, and are less likely to be affected by daily variations than a single direct measurement (Baxter et al. 2018; Lautenbacher and Neyse 2020). A low 2D:4D ratio, common in males, is positively related to prenatal testosterone, whereas a high 2D:4D ratio, common in females, is positively associated with prenatal estrogen (Fink et al. 2003; Manning 2011; Manning and Fink 2018). 2D:4D ratio in the right hand was found to be a better indicator of prenatal testosterone exposure than that in left hand (Hönekopp and Watson 2010). The role of prenatal sex hormones in generating sex differences in 2D:4D is supported by experimental studies in animal models (Zheng and Cohn 2011), correlational studies in humans (Lutchmaya et al. 2004; Ventura et al. 2013), opposite-sex twin studies (Voracek and Dressler 2007), and studies on individuals with specific genetic conditions like congenital adrenal hyperplasia (CAH) (Brown et al. 2002; Rivas et al. 2014), Klinefelter’s syndrome (Manning et al. 2013; Chang et al. 2015), and androgen insensitivity syndrome (AIS) (Berenbaum et al. 2009; Van Hemmen et al. 2017). However, the strength of the association between prenatal hormone exposure and 2D:4D may be relatively small, and individual variation in 2D:4D also reflects other factors including postnatal hormonal levels (Knickmeyer et al. 2011; McIntyre and Alexander 2011), genetic variation (Paul et al. 2006; Voracek and Dressler 2007; Hiraishi et al. 2012; Kalichman et al. 2019), and impaired fetal growth (Ronalds et al. 2002). Nevertheless, considering the difficulties in obtaining direct measurements of prenatal hormonal exposure, digit ratios remain the most accessible measure for prenatal hormonal exposure.
We also acknowledge that sexual differentiation in human brain could be influenced by many factors other than gonadal steroid exposure, as evidenced from rodent and human studies. In particular, the activity of genes on the sex chromosomes could have a significant role in determining sex-specific growth patterns of the brain. This is evident from studies in individuals with complete androgen insensitivity syndrome (CAIS) where external body phenotype is female, but the karyotype is XY. Regional brain volumes in XY individuals with CAIS were found to be similar to non-CAIS (XX) females in some areas, whereas it is similar to non-CAIS (XY) males in other areas (Savic et al. 2017). Of particular relevance to the current study, among youth of different karyotypes (between 5 and 25 years of age), increases in the number of X chromosome are associated with a decrease in total brain volume, cortical volume, and cortical surface area, while increases in the number of Y chromosomes are associated with increased total brain volume, cortical volume, and cortical surface area (Raznahan et al. 2016). Specific genes involved in these patterns have not yet been identified but potential candidates include Sry (a Y-linked gene that is involved in male sexual development and is also expressed in the developing male brain) (Dewing et al. 2006), Xist (a noncoding RNA on the X chromosome that plays a major role in the X-inactivation process (Arnold 2017), and a variety of X-linked escapee genes located outside the pseudoautosomal region (PAR) (Disteche 2012). Sex differences can also arise due to maternal versus paternal imprinting of the X chromosome (Bonthuis et al. 2015), the action of Mullerian inhibiting substance (Wang et al. 2009), and environmental effects that are difficult to separate from biological effects. Ultimately, all these factors act in parallel or in interaction with each other to bring about sexual differentiation.
In conclusion, this is the first study to explore potential associations between gonadal steroid exposure during early life and infant brain surface area. Strengths of the current study include the use of a large prospective, longitudinal cohort, inclusion of state-of-the-art neuroimaging measures, and rigorous quality control of both neuroimaging and genetic data. Limitations are primarily related to the challenges of measuring gonadal steroid exposure during the prenatal and early postnatal period and have already been discussed at length. In summary, our current work suggests that variation in testosterone during both the prenatal and postnatal period may contribute to cortical surface area development and predicts interindividual variation in females, but not in males.
Notes
We thank our participating families and staff in the UNC Biomedical Research Imaging Center (BRIC), the UNC Neuro Image Research and Analysis Laboratories (NIRAL), the UNC Early Brain Development Study (EBDS), the UNC Cytokine & Biomarker Analysis Facility, the UNC BioSpecimen Processing Facility (BSP), and the UNC Biobehavioral Laboratory (BBL). Conflict of Interest: The authors have no conflicts of interest to declare.
Funding
National Institutes of Health (MH064065, MH070890, HD053000 to J.H.G., MH092335, MH083045 to R.C.K., HD003110, EB005149 to M.S., MH116225, MH123202 to G.L., MH117943 to L.W. and G.L., and NS007431 to S.J.); the Brain & Behavior Research Foundation, and the John and Polly Sparks Foundation, Bank of America, Trustee (NARSAD Young Investigator Grant to K.X.); and the National Alliance for Autism Research (NAAR), which has since merged with Autism Speaks (to J.H.G. and R.C.K.).
References
Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. 1992. Methylation of Hpaii and Hhai sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X-chromosome inactivation.
McCarthy MM, Crews D. 2008. Epigenetics--new frontiers in neuroendocrinology.